Halozyme Therapeutics Inc (NASDAQ:HALO)

32.18
Delayed Data
As of Dec 01
 -0.70 / -2.13%
Today’s Change
32.16
Today|||52-Week Range
56.40
-24.65%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close32.88
Today’s open33.76
Day’s range32.18 - 33.63
Volume69,685
Average volume (3 months)770,405
Market cap$4.8B
Data as of 4:00pm ET, 12/01/2021

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+189.51%
Earnings growth (next 5 years)+41.00%
Revenue growth (last year)+36.53%
P/E ratio11.5
Price/Sales22.58
Price/Book30.26

Competitors

 Today’s
change
Today’s
% change
TLRYTilray Inc-0.86-8.50%
TWSTTwist Bioscience Cor...-8.37-8.76%
KODKodiak Sciences Inc-3.72-4.05%
----
Data as of 4:49pm ET, 12/01/2021

Financials

Next reporting dateFebruary 28, 2022
EPS forecast (this quarter)$0.40
Annual revenue (last year)$267.6M
Annual profit (last year)$129.1M
Net profit margin48.24%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts